HO affects nearly 65 percent of wounded members of the U.S. military and there isn’t currently an effective treatment. However, a new study from the Children’s Hospital of Philadelphia has shown that a new drug can prevent abnormal buildup of bone tissue.
The study treated mice with retinoid agonists, which showed good results in preventing HO with minimal side effects. The study was funded almost entirely by the Orthopaedic Extremity Trauma Research Program, which is supported by AAOS, Orthopaedic Trauma Association and the American Association of Hip and Knee Surgeons.
Read the AAOS news release on HO.
– AAOS Launches Educational Enhancement Fund
– AAOS: Pushing Forward With Healthcare Reform
– AAOS: 10 Biggest Stories in Orthopedics for 2010
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
